• Mashup Score: 2
    Program Guide – ASCO Meeting Program Guide - 6 month(s) ago

    Nathan W. Sweeney HealthTree, Lehi, UT Nathan W. Sweeney, Jenny Ahlstrom, Michael A. Thompson HealthTree, Lehi, UT, CrowdCare Foundation, Draper, UT, Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI Takeda, Sanofi and GSK for HealthTree Background: Multiple myeloma (MM) prognostic risk factors include cancer genetics as well as imaging characteristics. In order to engage the patient (pt) community regarding genetic testing and diagnostic imaging we utilized a patient-cen

    Source: meetings.asco.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      . @HealthtreeMM Patient Portal mediated myeloma patient reported diagnostic imaging and pathology testing - @NSweeneyPhd @AhlstromJenny @mtmdphd J Clin Oncol 38: 2020 (suppl; abstr e20565) #ASCO20 https://t.co/CRLXETpeMm #mmsm #oncorad #oncopath https://t.co/V1FlI7DNBm

  • Mashup Score: 0
    Program Guide – ASCO Meeting Program Guide - 11 month(s) ago

    AuthorsNathan W. SweeneyHealthTree, Lehi, UTNathan W. Sweeney, Jenny Ahlstrom, Michael A. ThompsonOrganizationsHealthTree, Lehi, UT, CrowdCare Foundation, Draper, UT, Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health, Milwaukee, WIAbstract DisclosuresResearch FundingPharmaceutical/Biotech CompanyTakeda, Sanofi and GSK for HealthTree Background: Multiple myeloma (MM)…

    Source: meetings.asco.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      . @HealthtreeMM Patient Portal mediated myeloma patient reported diagnostic imaging and pathology testing - @NSweeneyPhd @AhlstromJenny @mtmdphd J Clin Oncol 38: 2020 (suppl; abstr e20565) #ASCO20 https://t.co/CRLXETpeMm #mmsm #oncorad #oncopath https://t.co/VfHapaN90k

  • Mashup Score: 0
    MOLECULAR GENETIC TESTING PATTERNS FOR PATIENTS WITH NEWLY... by Daniel Pollyea - 11 month(s) ago

    Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event Platform powered by MULTILEARNING LMS.

    Source: library.ehaweb.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Molecular Genetic Testing Patterns in Newly Dx AML: CONNECT® Registry [May 18, 2017] @DanPollyea et al. Abstract: E923 #EHA22 https://t.co/NOvxkVe5nr #NCT01688011 #AMLsm #leusm #oncopath #camoldx #PrecisionMedicine https://t.co/WY1p7tOThu

  • Mashup Score: 0
    Effective use of Twitter and Facebook in pathology practice - PubMed - 12 month(s) ago

    Social networking has become a part of daily life for most people. In the era of globalization, it has become indispensable for effective communication between friends and peers across the world. Today, social media use is not restricted only to our personal lives; it is becoming increasingly incorp …

    Source: PubMed
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      Effective use of Twitter and Facebook in pathology practice [1/4/18] Oltulu, Mannan, @JMGardnerMD Hum Pathol https://t.co/Z3Yme0Xn0N #oncopath

  • Mashup Score: 0
    Program Guide – ASCO Meeting Program Guide - 1 year(s) ago

    AuthorsNathan W. SweeneyHealthTree, Lehi, UTNathan W. Sweeney, Jenny Ahlstrom, Michael A. ThompsonOrganizationsHealthTree, Lehi, UT, CrowdCare Foundation, Draper, UT, Aurora Cancer Care, Aurora Research Institute, Advocate Aurora Health, Milwaukee, WIAbstract DisclosuresResearch FundingPharmaceutical/Biotech CompanyTakeda, Sanofi and GSK for HealthTree Background: Multiple myeloma (MM)…

    Source: meetings.asco.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of mtmdphd
      mtmdphd

      HealthTree Patient Portal mediated myeloma patient reported diagnostic imaging and pathology testing - @NSweeneyPhd @AhlstromJenny @mtmdphd @JCO_ASCO38: 2020 (suppl; abstr e20565) #ASCO20 https://t.co/CRLXETpMBU #mmsm #oncorad #oncopath @myelomacrowd https://t.co/i86SDdpjbw

  • Mashup Score: 2
    Human papillomavirus 42 drives digital papillary adenocarcinoma and elicits a germ-cell like program conserved in HPV-positive cancers - 2 year(s) ago

    Abstract. The skin is exposed to viral pathogens, but whether they contribute to the oncogenesis of skin cancers has not been systematically explored. Here we investigated 19 skin tumor types by analyzing off-target reads from commonly available next-generation sequencing data for viral pathogens. We identified human papillomavirus 42 (HPV42) in 96% (n = 45/47) of digital papillary adenocarcinoma…

    Source: American Association for Cancer Research
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VivekSubbiah
      VivekSubbiah

      Human papillomavirus 42 drives digital papillary adenocarcinoma and elicits a germ-cell like program conserved in HPV-positive cancers | Cancer Discovery | American Association for Cancer Research https://t.co/jR3VioNanE

    • Profile photo of NatRevClinOncol
      NatRevClinOncol

      In a screening of 214 samples from 19 types of skin cancer, 45 of 47 digital papillary adenocarcinoma samples were positive for HPV42, which so far had been considered a low-risk HPV variant: https://t.co/YysF6yvRyq #skcsm #oncopath

Load More